Stephan Witte has been appointed chief medical officer of Adrenomed AG in Germany where he will guide development of the company’s late-stage product for septic shock. Dr Witte was previously head of clinical science and operations at Atriva Therapeutics GmbH, a developer of antiviral therapeutics. He has also managed clinical development and regulatory affairs at France-based Inotrem SA, a biotech company specialising in inflammatory syndromes.
Dr Witte holds a diploma in chemistry and a PhD in biochemistry and immunology from the University of Konstanz in Germany.
Adrenomed announced the appointment on 1 February 2023.
Copyright 2023 Evernow Publishing Ltd